190 related articles for article (PubMed ID: 8217084)
1. Chromosome 11Q13 amplification in head and neck squamous cell carcinoma.
Williams ME; Gaffey MJ; Weiss LM; Wilczynski SP; Schuuring E; Levine PA
Arch Otolaryngol Head Neck Surg; 1993 Nov; 119(11):1238-43. PubMed ID: 8217084
[TBL] [Abstract][Full Text] [Related]
2. Chromosome 11q13 amplification in head and neck squamous cell carcinoma. Association with poor prognosis.
Meredith SD; Levine PA; Burns JA; Gaffey MJ; Boyd JC; Weiss LM; Erickson NL; Williams ME
Arch Otolaryngol Head Neck Surg; 1995 Jul; 121(7):790-4. PubMed ID: 7598859
[TBL] [Abstract][Full Text] [Related]
3. Cyclin D1 (PRAD1, CCND1) and glutathione-S-transferase pi gene expression in head and neck squamous cell carcinoma.
Gaffey MJ; Iezzoni JC; Meredith SD; Boyd JC; Stoler MH; Weiss LM; Zukerberg LR; Levine PA; Arnold A; Williams ME
Hum Pathol; 1995 Nov; 26(11):1221-6. PubMed ID: 7590696
[TBL] [Abstract][Full Text] [Related]
4. Chromosome 11q13, c-erbB-2, and c-myc amplification in invasive breast carcinoma: clinicopathologic correlations.
Gaffey MJ; Frierson HF; Williams ME
Mod Pathol; 1993 Nov; 6(6):654-9. PubMed ID: 7905628
[TBL] [Abstract][Full Text] [Related]
5. High-throughput tissue microarray analysis of 11q13 gene amplification (CCND1, FGF3, FGF4, EMS1) in urinary bladder cancer.
Zaharieva BM; Simon R; Diener PA; Ackermann D; Maurer R; Alund G; Knönagel H; Rist M; Wilber K; Hering F; Schönenberger A; Flury R; Jäger P; Fehr JL; Mihatsch MJ; Gasser T; Sauter G; Toncheva DI
J Pathol; 2003 Dec; 201(4):603-8. PubMed ID: 14648664
[TBL] [Abstract][Full Text] [Related]
6. Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression.
Akervall JA; Michalides RJ; Mineta H; Balm A; Borg A; Dictor MR; Jin Y; Loftus B; Mertens F; Wennerberg JP
Cancer; 1997 Jan; 79(2):380-9. PubMed ID: 9010112
[TBL] [Abstract][Full Text] [Related]
7. Amplification of 11q13 DNA markers in head and neck squamous cell carcinomas: correlation with clinical outcome.
Muller D; Millon R; Velten M; Bronner G; Jung G; Engelmann A; Flesch H; Eber M; Methlin G; Abecassis J
Eur J Cancer; 1997 Nov; 33(13):2203-10. PubMed ID: 9470807
[TBL] [Abstract][Full Text] [Related]
8. Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas.
Schuuring E; Verhoeven E; Mooi WJ; Michalides RJ
Oncogene; 1992 Feb; 7(2):355-61. PubMed ID: 1532244
[TBL] [Abstract][Full Text] [Related]
9. EMS1 gene amplification correlates with poor prognosis in squamous cell carcinomas of the head and neck.
Rodrigo JP; García LA; Ramos S; Lazo PS; Suárez C
Clin Cancer Res; 2000 Aug; 6(8):3177-82. PubMed ID: 10955801
[TBL] [Abstract][Full Text] [Related]
10. PRAD-1 (CCND1)/cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma.
Callender T; el-Naggar AK; Lee MS; Frankenthaler R; Luna MA; Batsakis JG
Cancer; 1994 Jul; 74(1):152-8. PubMed ID: 8004570
[TBL] [Abstract][Full Text] [Related]
11. Clinical application of fluorescence in situ hybridization for chromosome 11q13 analysis in head and neck cancer.
Alavi S; Namazie A; Calcaterra TC; Wang MB; Srivatsan ES
Laryngoscope; 1999 Jun; 109(6):874-9. PubMed ID: 10369274
[TBL] [Abstract][Full Text] [Related]
12. Frequent amplification of 11q13 DNA markers is associated with lymph node involvement in human head and neck squamous cell carcinomas.
Muller D; Millon R; Lidereau R; Engelmann A; Bronner G; Flesch H; Eber M; Methlin G; Abecassis J
Eur J Cancer B Oral Oncol; 1994; 30B(2):113-20. PubMed ID: 8032300
[TBL] [Abstract][Full Text] [Related]
13. A consistent pattern of RIN1 rearrangements in oral squamous cell carcinoma cell lines supports a breakage-fusion-bridge cycle model for 11q13 amplification.
Shuster MI; Han L; Le Beau MM; Davis E; Sawicki M; Lese CM; Park NH; Colicelli J; Gollin SM
Genes Chromosomes Cancer; 2000 Jun; 28(2):153-63. PubMed ID: 10825000
[TBL] [Abstract][Full Text] [Related]
14. Expression of cyclin D1 and EMS1 in bladder tumours; relationship with chromosome 11q13 amplification.
Bringuier PP; Tamimi Y; Schuuring E; Schalken J
Oncogene; 1996 Apr; 12(8):1747-53. PubMed ID: 8622895
[TBL] [Abstract][Full Text] [Related]
15. Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors.
Namazie A; Alavi S; Olopade OI; Pauletti G; Aghamohammadi N; Aghamohammadi M; Gornbein JA; Calcaterra TC; Slamon DJ; Wang MB; Srivatsan ES
Laryngoscope; 2002 Mar; 112(3):472-81. PubMed ID: 12148857
[TBL] [Abstract][Full Text] [Related]
16. Visualization of INT2 and HST1 amplification in oral squamous cell carcinomas.
Lese CM; Rossie KM; Appel BN; Reddy JK; Johnson JT; Myers EN; Gollin SM
Genes Chromosomes Cancer; 1995 Apr; 12(4):288-95. PubMed ID: 7539284
[TBL] [Abstract][Full Text] [Related]
17. Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas.
Rodrigo JP; García-Carracedo D; García LA; Menéndez S; Allonca E; González MV; Fresno MF; Suárez C; García-Pedrero JM
J Pathol; 2009 Mar; 217(4):516-23. PubMed ID: 18991334
[TBL] [Abstract][Full Text] [Related]
18. A differential PCR system for the determination of CCND1 (cyclin D1) gene amplification in head and neck squamous cell carcinomas.
Schneeberger C; Eder S; Swoboda H; Ullrich R; Zeillinger R
Oral Oncol; 1998 Jul; 34(4):257-60. PubMed ID: 9813719
[TBL] [Abstract][Full Text] [Related]
19. EMS1 amplification can occur independently of CCND1 or INT-2 amplification at 11q13 and may identify different phenotypes in primary breast cancer.
Hui R; Campbell DH; Lee CS; McCaul K; Horsfall DJ; Musgrove EA; Daly RJ; Seshadri R; Sutherland RL
Oncogene; 1997 Sep; 15(13):1617-23. PubMed ID: 9380415
[TBL] [Abstract][Full Text] [Related]
20. PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas.
Jares P; Fernández PL; Campo E; Nadal A; Bosch F; Aiza G; Nayach I; Traserra J; Cardesa A
Cancer Res; 1994 Sep; 54(17):4813-7. PubMed ID: 8062283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
